Advertisement
Home 2020

Yearly Archives: 2020

First Blood Test for Alzheimer Disease Available in U.S.

0

Test from C2N Diagnostics is meant for people 60 years and older who have cognitive issues and are being assessed for Alzheimer disease

Copy of Black Children Hit Especially Hard by COVID-19 Inflammatory Syndrome

Racial Disparity Seen in COVID-19 Multisystem Inflammatory Syndrome

0

Rates more than three times higher in Black children in New York City versus White children

Risk for Bone Fractures Up for Patients With Psoriatic Diseases

0

No difference in bone mineral density and no increased risk for osteoporosis seen for psoriatic disease patients versus controls

CVD Risk Higher in T2DM Even With Optimal Risk Factor Management

0

Those with T2DM with optimal risk factor control have greater risk for cardiovascular disease events versus those without T2DM

ART Treatment Not Tied to Higher Risk for Ovarian Cancer

0

Increased risk compared with general population likely due to nulliparity among ART-treated women; risk not increased versus subfertile women

AKI Common in U.S. Veterans Hospitalized With COVID-19

Canagliflozin Beneficial Even for Advanced Kidney Disease

0

Canagliflozin slows progression of kidney disease in participants with eGFR <30 mL/min/1.73 m2 with no increase in AKI

Screening

Breast Cancer, CRC Incidence No Different With, Without MS

0

However, bladder cancer incidence and mortality rates higher among individuals with multiple sclerosis

Prognosis Good With Negative Biopsy in Active Surveillance

0

Negative biopsies during active surveillance for low-risk prostate cancer tied to more favorable outcomes

[EMB 11/19 @00:01] 2009 to 2018 Saw Increase in Incidence of NAFLD in Children

CT Use Down for ED Evaluation of Abdominal Pain in Children

0

Among adults with abdominal pain, use of CT in emergency department consistently increased from 1997 to 2016

Los pacientes con la peor COVID-19 quizá sean los mejores donantes de plasma

COVID-19 Outcomes Not Improved With Convalescent Plasma

0

Clinical status, mortality did not differ for convalescent plasma versus placebo in adults with severe COVID-19 pneumonia